Stock CGTX COGNITION THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Cognition Therapeutics, Inc.

Equities

CGTX

US19243B1026

Real-time Estimate Cboe BZX
Other stock markets
 02:20:38 2024-06-10 pm EDT 		5-day change 1st Jan Change
2.01 USD +3.08% Intraday chart for Cognition Therapeutics, Inc. +0.30% +8.44%
Jun. 07 Chardan Research Initiates Cognition Therapeutics With Buy Rating, $11 Price Target MT
May. 29 HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Chardan Research Initiates Cognition Therapeutics With Buy Rating, $11 Price Target
MT
HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target
MT
Ladenburg Thalmann Cuts Cognition Therapeutics' Price Target to $6 From $10, Keeps Buy Rating
MT
B. Riley Cuts Cognition Therapeutics' PT to $5 From $15, Notes Near-Term Dilution, Expanding R&D Efforts to Execute on Phase II/III Programs; Keeps Buy Rating
MT
Oppenheimer Adjusts Cognition Therapeutics Price Target to $9 From $18, Maintains Outperform Rating
MT
Cantor Fitzgerald Starts Cognition Therapeutics at Overweight With $12 Price Target
MT
Ladenburg Thalmann Starts Cognition Therapeutics at Buy With $10 Price Target
MT
B. Riley Lowers Cognition Therapeutics' PT to $15 from $20, Keeps Buy Rating
MT
Oppenheimer Adjusts Cognition Therapeutics' Price Target to $18 From $22, Maintains Outperform Rating
MT
B. Riley Lowers Cognition Therapeutics' Price Target to $20 from $27 After Revising Cost Capital Assumptions, Keeps Buy Rating
MT
Oppenheimer Starts Cognition Therapeutics at Outperform with $22 PT On Potential Offered By Lead Dementia Drug Candidate CT1812
MT
B. Riley Starts Cognition Therapeutics at Buy with $27 PT, Notes Conviction in Proprietary, Mid-Stage Pipeline
MT
Oppenheimer Starts Cognition Therapeutics at Outperform with $22 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CGTX Stock
  4. News Cognition Therapeutics, Inc.
  5. Analyst Reco.